Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088635947> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2088635947 endingPage "289" @default.
- W2088635947 startingPage "289" @default.
- W2088635947 abstract "Valproic acid (VPA) exhibits important pharmacological properties but has been reported to trigger side effects, notably on the hematological system. We previously reported that VPA affects hematopoietic homeostasis by inhibiting erythroid differentiation and promoting myeloid and megakaryocyte differentiation. Here, we analyzed the effect of VPA on regulatory factors involved in erythro-megakaryocytic differentiation pathways, including transcription factors and microRNAs (miRs). We demonstrate that VPA inhibited erythroid differentiation in erythropoietin (Epo)-stimulated TF1 leukemia cells and CD34+/hematopoietic stem cells (HSCs) and in aclacinomycin-(Acla)-treated K562 cells. Mir-144/451 gene expression was decreased in all erythroid and megakaryocyte models in correlation with GATA-1 inhibition. In Epo-stimulated CD34+/HSCs, VPA induced the expression of the ETS family transcription factors PU.1, ETS-1, GABP-α, Fli-1 and GATA-2, which are all known to be negative regulators of erythropoiesis, while it promoted the megakaryocytic pathway. PU.1 and ETS-1 expression were induced in correlation with miR-155 inhibition; however, the GATA-1/PU.1 interaction was promoted. Using megakaryoblastic Meg-01 cells, we demonstrated that VPA induced megakaryocyte morphological features and CD61 expression. GATA-2 and miR-27a expression were increased in correlation with a decrease in RUNX1 mRNA expression, suggesting megakaryocyte differentiation. Finally, by using valpromide and the Class I HDACi MS-275, we validated that the well-described HDACi activity of VPA is not required in the inhibitory effect on erythropoiesis. Overall, this report shows that VPA modulates the erythro-megakaryocytic differentiation program through regulatory micro-networks involving GATA and ETS transcription factors and miRNAs, notably the GATA-1/miR-144/451 axis." @default.
- W2088635947 created "2016-06-24" @default.
- W2088635947 creator A5019572077 @default.
- W2088635947 creator A5023411296 @default.
- W2088635947 creator A5035525469 @default.
- W2088635947 date "2004-01-01" @default.
- W2088635947 modified "2023-09-30" @default.
- W2088635947 title "Erythrophagocytosis by leukemic blasts in AML-M5a with t(8;16)(q13;p13) chromosome abnormality" @default.
- W2088635947 doi "https://doi.org/10.1016/s0344-0338(04)80532-6" @default.
- W2088635947 hasPublicationYear "2004" @default.
- W2088635947 type Work @default.
- W2088635947 sameAs 2088635947 @default.
- W2088635947 citedByCount "0" @default.
- W2088635947 crossrefType "journal-article" @default.
- W2088635947 hasAuthorship W2088635947A5019572077 @default.
- W2088635947 hasAuthorship W2088635947A5023411296 @default.
- W2088635947 hasAuthorship W2088635947A5035525469 @default.
- W2088635947 hasConcept C10205521 @default.
- W2088635947 hasConcept C104317684 @default.
- W2088635947 hasConcept C109159458 @default.
- W2088635947 hasConcept C126322002 @default.
- W2088635947 hasConcept C153911025 @default.
- W2088635947 hasConcept C192196715 @default.
- W2088635947 hasConcept C2778193527 @default.
- W2088635947 hasConcept C2778248108 @default.
- W2088635947 hasConcept C2778729363 @default.
- W2088635947 hasConcept C2779282312 @default.
- W2088635947 hasConcept C2779703530 @default.
- W2088635947 hasConcept C2779705218 @default.
- W2088635947 hasConcept C2780844101 @default.
- W2088635947 hasConcept C28328180 @default.
- W2088635947 hasConcept C502942594 @default.
- W2088635947 hasConcept C54355233 @default.
- W2088635947 hasConcept C71924100 @default.
- W2088635947 hasConcept C86339819 @default.
- W2088635947 hasConcept C86803240 @default.
- W2088635947 hasConcept C95444343 @default.
- W2088635947 hasConceptScore W2088635947C10205521 @default.
- W2088635947 hasConceptScore W2088635947C104317684 @default.
- W2088635947 hasConceptScore W2088635947C109159458 @default.
- W2088635947 hasConceptScore W2088635947C126322002 @default.
- W2088635947 hasConceptScore W2088635947C153911025 @default.
- W2088635947 hasConceptScore W2088635947C192196715 @default.
- W2088635947 hasConceptScore W2088635947C2778193527 @default.
- W2088635947 hasConceptScore W2088635947C2778248108 @default.
- W2088635947 hasConceptScore W2088635947C2778729363 @default.
- W2088635947 hasConceptScore W2088635947C2779282312 @default.
- W2088635947 hasConceptScore W2088635947C2779703530 @default.
- W2088635947 hasConceptScore W2088635947C2779705218 @default.
- W2088635947 hasConceptScore W2088635947C2780844101 @default.
- W2088635947 hasConceptScore W2088635947C28328180 @default.
- W2088635947 hasConceptScore W2088635947C502942594 @default.
- W2088635947 hasConceptScore W2088635947C54355233 @default.
- W2088635947 hasConceptScore W2088635947C71924100 @default.
- W2088635947 hasConceptScore W2088635947C86339819 @default.
- W2088635947 hasConceptScore W2088635947C86803240 @default.
- W2088635947 hasConceptScore W2088635947C95444343 @default.
- W2088635947 hasIssue "4" @default.
- W2088635947 hasLocation W20886359471 @default.
- W2088635947 hasOpenAccess W2088635947 @default.
- W2088635947 hasPrimaryLocation W20886359471 @default.
- W2088635947 hasRelatedWork W1992643627 @default.
- W2088635947 hasRelatedWork W2070944615 @default.
- W2088635947 hasRelatedWork W2074213253 @default.
- W2088635947 hasRelatedWork W2623762817 @default.
- W2088635947 hasRelatedWork W2891065303 @default.
- W2088635947 hasRelatedWork W2979578144 @default.
- W2088635947 hasRelatedWork W2979744827 @default.
- W2088635947 hasRelatedWork W2979936029 @default.
- W2088635947 hasRelatedWork W4255878380 @default.
- W2088635947 hasRelatedWork W195552030 @default.
- W2088635947 hasVolume "200" @default.
- W2088635947 isParatext "false" @default.
- W2088635947 isRetracted "false" @default.
- W2088635947 magId "2088635947" @default.
- W2088635947 workType "article" @default.